Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-02-23 @ 12:19 PM
Study NCT ID:
NCT03705403
Status:
TERMINATED
Last Update Posted:
2025-01-30
First Post:
2018-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study
Sponsor:
Maastricht University Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UM2018IMMUNOSABR2RLPL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None